Rapid Activity of Platelet Inhibitor Drugs Study (RAPID 2)

Trial Profile

Rapid Activity of Platelet Inhibitor Drugs Study (RAPID 2)

Phase of Trial: Phase IV

Latest Information Update: 06 Oct 2015

At a glance

  • Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Aspirin; Bivalirudin
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Biomarker; Pharmacodynamics
  • Acronyms RAPID2
  • Most Recent Events

    • 06 Oct 2015 Status is changed from recruiting to completed as per CT.gov
    • 18 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top